Evidence map›Paper›PMID 22790178›Full record

ReviewNature reviews. Immunology2012

The immunological life cycle of tuberculosis.

Joel D Ernst

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 317 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
317citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

317 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Revolutionizing diagnosis of pulmonaryFrontiers in microbiology · 2024
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Respiratory immunology: an ancient yet emerging interdisciplinary field.Chinese medical journal pulmonary and critical care medicine · 2026
    Article
  7. Article
  8. Antigen-experienced airway CD8Science advances · 2026
    Article
  9. Lung Resident T Cells Across the Spectrum of TB Infection and Disease.bioRxiv : the preprint server for biology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. ARNA (New York, N.Y.) · 2026
    Article
  15. GIDISdb: a gene expression database for exploring human immune responses in infectious diseases.Database : the journal of biological databases and curation · 2026
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

257 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Joel D ErnstDepartment of Medicine, New York University School of Medicine, 522 First Avenue, Smilow 901, New York, New York 10016, USA. joel.ernst@med.nyu.edu

Funding

Initiation of the Immune Response to M. tuberculosisR01AI051242 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ERNST, JOEL D. · 2002 to 2019
$8.3M
Mycobacterium tuberculosis antigen diversityR01AI090928 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ERNST, JOEL D., GAGNEUX, SEBASTIEN · 2010 to 2014
$3.2M
ASSEMBLY OF INFECTIOUS BLUETONGUE VIRION FROM CDNA CLONER01AI048041 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROY, POLLY · 2000 to 2002
$737k
NIAID NIH HHS AI048041NIAID NIH HHS AI051242NIAID NIH HHS AI090928
6 · The paper itself

Abstract

Immune responses to Mycobacterium tuberculosis are only partially effective; they drive the bacteria into a latent state, but rarely eliminate them. Unfortunately, the latent state of M. tuberculosis is reversible, and reactivation tuberculosis is the source of most transmission. Studies in animal models and in humans have not yet yielded a comprehensive picture of the mechanisms or correlates of immunity to M. tuberculosis infection, or of why immunity fails to eradicate the pathogen. This Review proposes that there are distinct stages in the immune response to M. tuberculosis that form an 'immunological life cycle'. It is hoped that this thesis will provide a framework for investigation to understand immunity to M. tuberculosis and to guide tuberculosis vaccine discovery and development.

Indexed as

AnimalsDisease Models, AnimalHumansImmunity, InnateMiceMycobacterium tuberculosisTuberculosis

Identifiers

PMID22790178

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.